Zobrazeno 1 - 3
of 3
pro vyhledávání: '"María del Carmen Pingarrón Santofimia"'
Autor:
María del Carmen Pingarrón Santofimia, Silvia Pilar González Rodríguez, Mariella Lilue, Santiago Palacios
Publikováno v:
Drugs in Context, Vol 9, Pp 1-10 (2020)
Selective estrogen receptor modulators (SERMs) exhibit varying agonist/antagonist activities on estrogen receptors in tissues, although most SERMs, including ospemifene, have agonist effects on bone. In this article, outcomes in relation to bone home
Externí odkaz:
https://doaj.org/article/e5130506186d4ca0a3d772cb266ad65b
Publikováno v:
Drugs in Context, Vol 9, p 1 (2020)
Women with breast cancer are at a higher risk of developing vulvar and vaginal atrophy (VVA), a major component of the genitourinary syndrome of menopause, due to the combined estrogen-depleting effects of chemotherapy, adjuvant hormone therapy, and
Externí odkaz:
https://doaj.org/article/ac70c61b31b04aa9a4aa8235e365be92
Autor:
Silvia Pilar González Rodríguez, María Del Carmen Pingarrón Santofimia, Santiago Palacios, Mariella Lilue
Publikováno v:
Drugs in Context
Drugs in Context, Vol 9, Pp 1-10 (2020)
Drugs in Context, Vol 9, Pp 1-10 (2020)
Selective estrogen receptor modulators (SERMs) exhibit varying agonist/antagonist activities on estrogen receptors in tissues, although most SERMs, including ospemifene, have agonist effects on bone. In this article, outcomes in relation to bone home
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ee54585762e24b8e3a0cd146727a1ba
https://doi.org/10.7573/dic.2020-3-3
https://doi.org/10.7573/dic.2020-3-3